Amphastar Pharmaceuticals, Inc. (FRA:29A)
Germany · Delayed Price · Currency is EUR 21.27
-0.01 (-0.05%)
At close: Jan 30, 2026
Amphastar Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 111.63 | 159.52 | 137.55 | 91.39 | 62.12 | 1.4 |
Depreciation & Amortization | 61.88 | 57.21 | 41.78 | 28.28 | 26.53 | 25.18 |
Other Amortization | 3.21 | 6.03 | 11.4 | 0.47 | 0.22 | - |
Loss (Gain) From Sale of Assets | -0.07 | 0.01 | 0.48 | 0.14 | -13.24 | 0.24 |
Asset Writedown & Restructuring Costs | - | - | 2.7 | - | - | - |
Loss (Gain) From Sale of Investments | -2.27 | -2.79 | 5.33 | -2.2 | 0.03 | -2.17 |
Loss (Gain) on Equity Investments | - | 0.57 | 1.98 | 1.18 | 0.21 | - |
Stock-Based Compensation | 26.7 | 24.37 | 20.24 | 17.86 | 18.69 | 20.5 |
Other Operating Activities | -16.98 | -16.98 | -13.74 | -15.75 | 5.39 | 0.82 |
Change in Accounts Receivable | -6.69 | -21.67 | -26.09 | -10.13 | -14.92 | -20.16 |
Change in Inventory | -54.54 | -48.8 | -1.72 | -11.75 | 1.26 | 15.3 |
Change in Accounts Payable | 40.2 | 63.56 | 13.24 | -0.74 | 3.63 | 20.09 |
Change in Income Taxes | 7.64 | 6.83 | -3.32 | -4.56 | 8.35 | -0.97 |
Change in Other Net Operating Assets | -18.43 | -14.48 | -6.32 | -5.01 | -0.27 | -2.95 |
Operating Cash Flow | 152.28 | 213.39 | 183.5 | 89.18 | 97.99 | 57.27 |
Operating Cash Flow Growth | -26.87% | 16.29% | 105.77% | -8.99% | 71.12% | 37.13% |
Capital Expenditures | -39.02 | -41.04 | -38.17 | -24.03 | -27.46 | -33.86 |
Sale of Property, Plant & Equipment | - | - | - | 0.42 | - | - |
Cash Acquisitions | - | -129 | -506.41 | - | - | - |
Sale (Purchase) of Intangibles | -2.25 | - | - | - | - | - |
Investment in Securities | 1.22 | 49.23 | -105.93 | -7.79 | 1.4 | -1.15 |
Other Investing Activities | -5.39 | -4.12 | 1.39 | -1.37 | -2.61 | -1.41 |
Investing Cash Flow | -45.44 | -124.93 | -649.12 | -32.78 | -28.67 | -36.42 |
Long-Term Debt Issued | - | 18.43 | 845 | - | 70 | 7.52 |
Long-Term Debt Repaid | - | -8.26 | -318.66 | -1.78 | -37.9 | -8.4 |
Total Debt Repaid | -0.23 | -8.26 | -318.66 | -1.78 | -37.9 | -8.4 |
Net Debt Issued (Repaid) | 10.58 | 10.17 | 526.34 | -1.78 | 32.1 | -0.88 |
Issuance of Common Stock | 0.87 | - | 10.97 | 15.66 | 15.93 | 23.17 |
Repurchase of Common Stock | -93.69 | -90.31 | -58.14 | -39.91 | -28.87 | -24.43 |
Other Financing Activities | -0.66 | -0.82 | -25.08 | -0.41 | -56.17 | -0.11 |
Financing Cash Flow | -82.89 | -80.95 | 454.09 | -26.44 | -37.02 | -2.25 |
Foreign Exchange Rate Adjustments | 0.21 | -0.19 | -0.28 | -0.22 | -0.22 | 0.35 |
Net Cash Flow | 24.15 | 7.31 | -11.8 | 29.75 | 32.08 | 18.96 |
Free Cash Flow | 113.26 | 172.35 | 145.34 | 65.15 | 70.54 | 23.41 |
Free Cash Flow Growth | -33.44% | 18.58% | 123.09% | -7.64% | 201.30% | 11209.66% |
Free Cash Flow Margin | 15.66% | 23.54% | 22.55% | 13.06% | 16.11% | 6.69% |
Free Cash Flow Per Share | 2.30 | 3.31 | 2.74 | 1.24 | 1.42 | 0.48 |
Cash Interest Paid | 23.56 | 26.81 | 17.57 | 3.02 | 2.11 | 2.2 |
Cash Income Tax Paid | 33.41 | 40.1 | 49 | 44.44 | 8.1 | 3.41 |
Levered Free Cash Flow | 112 | 18.89 | 241.41 | 57.67 | 56.9 | 33.28 |
Unlevered Free Cash Flow | 129.59 | 34.94 | 250.67 | 58.36 | 57.23 | 33.51 |
Change in Working Capital | -31.83 | -14.55 | -24.21 | -32.18 | -1.95 | 11.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.